Kendra Beneski
Neurology with Special Qualifications in Child Neurology · Plano, TXNPI 1497149595
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $652 and has fallen 89.7% since, to $67 in 2024.
Across 71 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$180
- Biohaven Pharmaceuticals, Inc.$145
- Eisai Inc.$138
- Greenwich Biosciences, Inc.$70
- Neurelis, Inc.$67
- Azurity Pharmaceuticals, Inc.$67
- plus $559 from 17 others
What the payments were for
- Food & beverage$1,227100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 12 | $180 |
| Biohaven Pharmaceuticals, Inc. | 9 | $145 |
| Eisai Inc. | 7 | $138 |
| Greenwich Biosciences, Inc. | 5 | $70 |
| Neurelis, Inc. | 4 | $67 |
| Azurity Pharmaceuticals, Inc. | 2 | $67 |
| Tris Pharma Inc | 4 | $67 |
| Zogenix Inc. | 3 | $66 |
| Ironshore Pharmaceuticals Inc. | 2 | $63 |
| UCB, Inc. | 4 | $63 |
| Corium, LLC | 2 | $42 |
| Adlon Therapeutics L.p. | 3 | $41 |
| SK Life Science, Inc. | 2 | $33 |
| Cranial Technologies, Inc | 2 | $27 |
| Amneal Pharmaceuticals LLC | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Aprecia Pharmaceuticals, LLC | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Neos Therapeutics, LP | 1 | $18 |
| Aquestive Therapeutics, Inc. | 1 | $16 |
| Harmony Biosciences LLC | 1 | $15 |
| Livanova USA, Inc. | 1 | $13 |
| Biomarin Pharmaceutical Inc. | 1 | $11 |
How this compares
$1,227 in reported general payments places this provider in the 55th percentile of 193 neurology with special qualifications in child neurology providers in Texas.
See all neurology with special qualifications in child neurology providers in Texas →
Other neurology with special qualifications in child neurology in Plano
- Robert ChudnowPlano$13K
- Safiullah ShareefPlano$11K
- Andrew HurdPlano$10K
- Mohsin MaqboolPlano$8K
- Lina ShahPlano$6K
- Gerald SoPlano$5K
- Patricia MirelesPlano$3K
- Roy EltermanDallas$5.9M
- Huda ZoghbiHouston$5.5M
- Diana CastroDenton$343K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.